Sign inJoin waitlistJoin the waitlist

Nishitha Reddy

Physician · Vanderbilt University Medical Center

Credentials: · · · · · ·

History

Vanderbilt University Medical Center
Present

ROSWELL PARK CANCER INSTITUTE
2003–2006
Hospice and Palliative Medicine
Vanderbilt University Medical Center
2002–2003
Internal Medicine
1999–2002
Bachelor of Medicine, Bachelor of Surgery - Ambedkar Medical College
1995–1999

Research

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia
New England Journal of Medicine · 2014 · 1,369 citations
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Cell · 2017 · 918 citations
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma
American Journal of Hematology · 2019 · 415 citations

BS
Bipin Savani
21 papers
Julie Vose
19 papers
Francisco Hernandez-Ilizaliturri
18 papers
Reem Karmali
17 papers
Andrew Evens
16 papers
JB
John Byrd
15 papers
MG
Martha Glenn
15 papers
Jonathon Cohen
14 papers · 1 as a fellow
Narendranath Epperla
14 papers
Shaoying Li
14 papers
TF
Timothy Fenske
14 papers
JG
John Greer
13 papers

Clinical trials

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma
Principal investigator · Terminated · Phase 1
Vanderbilt-Ingram Cancer Center
2018–2019
Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Principal investigator · Completed · Phase 1
Virginia Commonwealth University
2010–2018
A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
Principal investigator · Terminated · Phase 2
Piramal Enterprises Limited
2009–2012
Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
Principal investigator · Completed · Phase 2
Vanderbilt-Ingram Cancer Center
2008–2014